...
机译:在BRCA突变携带者风险降低手术后神经和后续癌症发病率
Cedars Sinai Med Ctr Dept Obstet &
Gynecol Div Gynecol Oncol 8635 West 3rd St Suite 280W Los;
Cedars Sinai Med Ctr Dept Obstet &
Gynecol Div Gynecol Oncol 8635 West 3rd St Suite 280W Los;
Cedars Sinai Med Ctr Dept Obstet &
Gynecol Div Gynecol Oncol 8635 West 3rd St Suite 280W Los;
Cedars Sinai Med Ctr Dept Obstet &
Gynecol Div Gynecol Oncol 8635 West 3rd St Suite 280W Los;
Cedars Sinai Med Ctr Dept Obstet &
Gynecol Div Gynecol Oncol 8635 West 3rd St Suite 280W Los;
Cedars Sinai Med Ctr Dept Obstet &
Gynecol Div Gynecol Oncol 8635 West 3rd St Suite 280W Los;
Cedars Sinai Med Ctr Dept Obstet &
Gynecol Div Gynecol Oncol 8635 West 3rd St Suite 280W Los;
Cedars Sinai Med Ctr Dept Obstet &
Gynecol Div Gynecol Oncol 8635 West 3rd St Suite 280W Los;
机译:降低风险的BRCA突变携带者手术后的隐匿性和后续癌症发生率
机译:在BRCA突变携带者风险降低手术后神经和后续癌症发病率
机译:BRCA突变携带者中降低风险的输卵管卵巢切除术(RRSO)后的隐匿性和后续妇科癌症
机译:一种用于检测BRCA1 / BRCA2基因突变和卵巢癌风险评估的集成微流体平台
机译:BRCA1和BRCA2突变携带者进行化学预防后的乳腺癌风险。
机译:在BRCA1 / 2突变载体的前瞻性队列中在降低风险降低的Salpingo-Oophorectomy中鉴定神秘的卵巢癌
机译:在BRCa1 / 2突变携带者的前瞻性队列中,在降低风险的输卵管卵巢切除术中发现了隐匿性卵巢癌
机译:降低风险的salpingo-Opherectomy用于预防BRCa1和BRCa2突变携带者的乳腺癌和卵巢癌的修饰物